SAN FRANCISCO, May 16, 2011 /PRNewswire/ -- Brown & Toland Physicians placed in the top tier of Californiaphysician groups for 2011, earning "Elite" status for the fifth year in a row as rated by the California Association of Physician Groups (CAPG).
Brown & Toland earned
"We are extremely proud to earn this recognition once again," said Richard Fish, CEO of Brown & Toland. "We owe a great thanks to our team of physicians and employees who work tirelessly to improve patient satisfaction, provide the best clinical care and integrate new technology. It's our excellence in these areas that have made us the leading physician group in San Francisco and is paving the way toward our success in the arena of accountable care."
This year, 76 medical groups and independent practice associations representing 11 million patients – roughly 90 percent of the HMO patient market – participated in the survey. These medical groups also care for roughly three million patients who are on PPO plans, Medicare and other types of health plans.
"I congratulate Brown & Toland Physicians and CEO Richard Fish for their continuing excellence," said Donald Crane, president and CEO of CAPG. "Their results on the Standards of Excellence survey demonstrate a true dedication to high quality, accountable patient care."
For more about the survey and results, visit www.capg.org.
About Brown & Toland Physicians
Brown & Toland is one of California's largest and most successful physician networks, with 850 physicians caring for nearly 300,000 HMO and PPO patients. Brown & Toland has earned numerous awards for clinical quality and patient satisfaction and is a leader in providing innovative technological solutions for its physicians. Learn more at www.brownandtoland.com.
SOURCE Brown & Toland Physicians
Subscribe to our Free Newsletters!
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...
Uterine/Endometrial cancer is the sixth most common cancer in women worldwide. Uterine cancer ...View All